SEB Concept Biotechnology - Klasse D (EUR)
LU0118405827
SEB Concept Biotechnology - Klasse D (EUR)/ LU0118405827 /
| NAV11/6/2024 |
Chg.+2.7080 |
Type of yield |
Investment Focus |
Investment company |
| 114.9830EUR |
+2.41% |
paying dividend |
Equity
Worldwide
|
SEB IM ▶ |
Investment strategy
The fund aims to increase the value of your investment over time and to outperform its benchmark.
The fund is actively managed and invests in stocks globally, primarily in the biotech sector. Investment decisions are based on in-depth (fundamental) analysis. The focus is on companies' business models, earning capacity, management and market positions. The return is determined by how much the fund's holdings increase or decrease in value during your holding period.
Investment goal
The fund aims to increase the value of your investment over time and to outperform its benchmark.
Master data
| Type of yield: |
paying dividend |
| Funds Category: |
Equity |
| Region: |
Worldwide |
| Branch: |
Sector Biotechnology |
| Benchmark: |
Nasdaq Biotechnology Index |
| Business year start: |
1/1 |
| Last Distribution: |
5/23/2024 |
| Depository bank: |
Skandinaviska Enskilda Banken AB, Lux |
| Fund domicile: |
Luxembourg |
| Distribution permission: |
Germany, Luxembourg, Czech Republic |
| Fund manager: |
Angelica Fatouros |
| Fund volume: |
142.41 mill.
EUR
|
| Launch date: |
10/16/2000 |
| Investment focus: |
- |
Conditions
| Issue surcharge: |
0.00% |
| Max. Administration Fee: |
1.50% |
| Minimum investment: |
- EUR |
| Deposit fees: |
- |
| Redemption charge: |
0.00% |
| Key Investor Information: |
Download (Print version) |
Investment company
| Funds company: |
SEB IM |
| Address: |
Stephanstraße 14 - 16, 60313, Frankfurt am Main |
| Country: |
Germany |
| Internet: |
seb.de/asset-management
|
Countries
| United States of America |
|
73.16% |
| United Kingdom |
|
6.84% |
| Cash |
|
4.97% |
| Netherlands |
|
2.95% |
| Sweden |
|
2.76% |
| Germany |
|
2.01% |
| Cayman Islands |
|
1.69% |
| Denmark |
|
1.65% |
| Bermuda |
|
1.53% |
| Ireland |
|
1.24% |
| Canada |
|
1.06% |
| Others |
|
0.14% |
Branches
| Pharma/Biotechnology |
|
90.10% |
| Cash |
|
4.97% |
| Healthcare services |
|
3.92% |
| Healthcare appliances |
|
0.87% |
| Others |
|
0.14% |
